Can micafungin be refrigerated?
The reconstituted product may be stored in the original vial for up to 24 hours at room temperature, 25°C (77°F). The diluted infusion should be protected from light and may be stored for up to 24 hours at room temperature, 25°C (77°F). Mycamine is preservative-free.
Is micafungin hepatotoxic?
Background: One of the major adverse events of caspofungin and micafungin is hepatotoxicity, however, there are few reports compared the incidence of hepatotoxicity between caspofungin and micafungin.
How long does it take micafungin to work?
Cover the IV bag during your infusion to protect the medicine from light. Use the medicine within 24 hours after mixing. Micafungin must be given slowly through an IV infusion, and each injection can take at least 1 hour to complete.
What is the pharmacokinetics of anidulafungin?
Anidulafungin displays linear pharmacokinetics across a wide range of once daily doses (15-130 mg). observed in healthy subjects based on population pharmacokinetic analyses. With the 200/100 mg steady state AUC of approximately 110 mg⋅h/l. anidulafungin. Plasma concentrations of anidulafungin in healthy men and women were similar. In multiple-dose
Does intravenous anidulafungin have a role in the ICU?
The pharmacokinetics of intravenous anidulafungin in adult intensive care unit (ICU) patients were assessed in this study and compared with historical data from a general patient population and healthy subjects. Intensive plasma sampling was performed over a dosing interval at steady state from 21 ICU patients with candidemia/invasive candidiasis.
How is Ecalta used to treat fungal infections?
Treatment with Ecalta should be started by a doctor who has experience in the management of invasive fungal infections. Ecalta is given as an initial dose of 200 mg on day one, followed by 100 mg each day from day two.
How many milligrams of anidulafungin can you take a day?
Anidulafungin displays linear pharmacokinetics across a wide range of once daily doses (15-130 mg). observed in healthy subjects based on population pharmacokinetic analyses.